We are a trustworthy firm from where customers can purchase several medicines including MEtformin Hydrochloride Prolonged Release And Glimepiride Tablets IP. This medicine is 100% effective and due to this factor, it is being highly demanded in the market. Experts prepare this medicine after detailed research work, they ensure to mix the ingredients in appropriate proportion. The manufactured MEtformin Hydrochloride Prolonged Release And Glimepiride Tablets IP is then sent to our testing lab for quality check and if the pass the conducted tests only then they are supplied in the market.
Pack Size: 10 Strip ( Piece)
Main Export Market(s): Worldwide
Note: Any information provided is not intended to serve as a substitute for clinical judgement and should not be relied upon solely for final treatment decisions . Please consult with your physician If you are not a medical professional, you should note that this website does not provide professional medical advice and is not intended to replace personal consultation with a qualified physician.
GlimNix-MF 2 Prolonged Release Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
GlimNix-MF 2 Prolonged Release Tablet should be taken with food. Take it regularly at the same time each day to get the most benefit. Your doctor will decide what dose is best for you and this may change from time to time according to how it is working according to your blood sugar levels.
Keep taking this medicine, even if you feel well or your blood sugar levels are controlled. If you stop it without consulting your doctor, your blood sugar levels could rise and put you at risk of kidney damage, blindness, nerve problems and loss of limbs. Remember that it is only part of a treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by your doctor. Your lifestyle plays a big part in controlling diabetes.
The most common side effect of GlimNix-MF 2 Prolonged Release Tablet is low blood glucose levels (hypoglycemia). Make sure you recognize the signs of having low blood glucose levels, such as sweating, dizziness, headache, and shaking and know how to deal with it. To prevent this, it's important to have regular meals and always carry a fast-acting source of glucose such as sugary food or fruit juice with you. Drinking alcohol can also increase your risk of low blood sugar levels and should be avoided. Other side effects that may be seen on taking this medicine include taste changes, nausea, diarrhea, stomach pain, headache and upper respiratory tract infection. Some people may find that they put on weight with this medicine.
You should not take it if you have type 1 diabetes mellitus, if you have diabetic ketoacidosis (high levels of acid in your blood), or if you have severe kidney or liver disease. Before taking this medicine, tell your doctor if you have ever had heart disease. It may not be suitable. Pregnant or breastfeeding women should also consult their doctor before taking it. Your blood sugar levels should be checked regularly and your doctor may also advise blood tests to monitor your blood cell counts and liver function.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youâ€™re worried about them
Use it as advised by your doctor or check the label for directions before use. GlimNix-MF 2 Prolonged Release Tablet is to be taken with food.
GlimNix-MF 2 Prolonged Release Tablet is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.
It is unsafe to consume alcohol with GlimNix-MF 2 Prolonged Release Tablet.
GlimNix-MF 2 Prolonged Release Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
GlimNix-MF 2 Prolonged Release Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
GlimNix-MF 2 Prolonged Release Tablet should be used with caution in patients with kidney disease. Dose adjustment of GlimNix-MF 2 Prolonged Release Tablet may be needed. Please consult your doctor.
Use of GlimNix-MF 2 Prolonged Release Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
GlimNix-MF 2 Prolonged Release Tablet should be used with caution in patients with liver disease. Dose adjustment of GlimNix-MF 2 Prolonged Release Tablet may be needed. Please consult your doctor.
GlimNix-MF 2 Prolonged Release Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.